Researchers at Oregon State University have developed a great new RNA annotation tool.
Researchers studying the biology of ageing have demonstrated a new strategy for stimulating autophagy, the process by which cells rebuild themselves by recycling their own worn-out parts.
A new way to simplify complex biomolecular data about tumours could in principle make it easier to prescribe the appropriate treatment for a specific patient.
DNA analysis from the remains of ancient Southeast Asian individuals has helped reveal new migration events.
An international research team has identified three new genes linked to the risk of Alzheimer’s disease.
A new study has discovered 30 new gene locations that determine how the heart responds to and recovers from exercise.
Precision medicine not only promises better treatment, but cost effective healthcare.
A study from University of Cambridge and Warwick Clinical Trials has shown that Herceptin treatment length could be halved.
A new report published today has urged the UK government to align the pharmaceutical industry as closely as possible to European regulation when Brexit eventually happens.
The results vary greatly by field, with social scientists and mathematicians being the most likely to disclose data.
Results of an international collaboration report a new association between the PM20D1 gene and Alzheimer’s disease (AD).
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer’s disease in mice.
Analysis of bladder cancer patients shows a significantly worse prognosis if mutations in ATM or RB1 are present.
Nuffield Council on Bioethics has released a briefing note covering the ethical considerations of AI in healthcare.
After 4 years, the IDO collaboration is over following disappointing trial results.